4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-22-013277
EVP & General Counsel sold 782 shares at $23.80 ($18,612)
- EVP & General Counsel acquired 2,213 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KIM AUSTIN D. EVP & General Counsel | 2022-02-23 | Option exercise | +2,213 | 15,413 | D | ||
| KIM AUSTIN D. EVP & General Counsel | 2022-02-23 | Sale | −782 | $23.80 | $18,612 | 14,631 | D |
| Derivatives | |||||||
| KIM AUSTIN D. EVP & General Counsel | 2022-02-23 | Option exercise · Restricted Stock Units | +2,213 | 6,642 | D | ||
| Open-market sales · 782 sh · avg $23.80 · $18,612 | |||||||
Loading xslF345X03/doc4.xml…